Copyright Reports & Markets. All rights reserved.

Global Oncology Molecular Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oncology Molecular Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 PCR
      • 1.4.3 INAAT
      • 1.4.4 DNA sequencing & NGS
      • 1.4.5 In situ hybridization
      • 1.4.6 DNA microarrays
      • 1.4.7 Other
    • 1.5 Market by Application
      • 1.5.1 Global Oncology Molecular Diagnostics Market Share by Application (2014-2025)
      • 1.5.2 Infectious diseases
      • 1.5.3 oncology
      • 1.5.4 Genetic tests
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Oncology Molecular Diagnostics Market Size
    • 2.2 Oncology Molecular Diagnostics Growth Trends by Regions
      • 2.2.1 Oncology Molecular Diagnostics Market Size by Regions (2014-2025)
      • 2.2.2 Oncology Molecular Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Oncology Molecular Diagnostics Market Size by Manufacturers
      • 3.1.1 Global Oncology Molecular Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Oncology Molecular Diagnostics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Oncology Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oncology Molecular Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Oncology Molecular Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Oncology Molecular Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Oncology Molecular Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Oncology Molecular Diagnostics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Oncology Molecular Diagnostics Market Size (2014-2019)
    • 5.2 Oncology Molecular Diagnostics Key Players in United States
    • 5.3 United States Oncology Molecular Diagnostics Market Size by Type
    • 5.4 United States Oncology Molecular Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Oncology Molecular Diagnostics Market Size (2014-2019)
    • 6.2 Oncology Molecular Diagnostics Key Players in Europe
    • 6.3 Europe Oncology Molecular Diagnostics Market Size by Type
    • 6.4 Europe Oncology Molecular Diagnostics Market Size by Application

    7 China

    • 7.1 China Oncology Molecular Diagnostics Market Size (2014-2019)
    • 7.2 Oncology Molecular Diagnostics Key Players in China
    • 7.3 China Oncology Molecular Diagnostics Market Size by Type
    • 7.4 China Oncology Molecular Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Oncology Molecular Diagnostics Market Size (2014-2019)
    • 8.2 Oncology Molecular Diagnostics Key Players in Japan
    • 8.3 Japan Oncology Molecular Diagnostics Market Size by Type
    • 8.4 Japan Oncology Molecular Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Oncology Molecular Diagnostics Market Size (2014-2019)
    • 9.2 Oncology Molecular Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Oncology Molecular Diagnostics Market Size by Type
    • 9.4 Southeast Asia Oncology Molecular Diagnostics Market Size by Application

    10 India

    • 10.1 India Oncology Molecular Diagnostics Market Size (2014-2019)
    • 10.2 Oncology Molecular Diagnostics Key Players in India
    • 10.3 India Oncology Molecular Diagnostics Market Size by Type
    • 10.4 India Oncology Molecular Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Oncology Molecular Diagnostics Market Size (2014-2019)
    • 11.2 Oncology Molecular Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Oncology Molecular Diagnostics Market Size by Type
    • 11.4 Central & South America Oncology Molecular Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Laboratories
      • 12.1.1 Abbott Laboratories Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Oncology Molecular Diagnostics Introduction
      • 12.1.4 Abbott Laboratories Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.1.5 Abbott Laboratories Recent Development
    • 12.2 Bayer Healthcare
      • 12.2.1 Bayer Healthcare Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Oncology Molecular Diagnostics Introduction
      • 12.2.4 Bayer Healthcare Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.2.5 Bayer Healthcare Recent Development
    • 12.3 Beckton Dickinson
      • 12.3.1 Beckton Dickinson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Oncology Molecular Diagnostics Introduction
      • 12.3.4 Beckton Dickinson Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.3.5 Beckton Dickinson Recent Development
    • 12.4 Cepheid
      • 12.4.1 Cepheid Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Oncology Molecular Diagnostics Introduction
      • 12.4.4 Cepheid Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.4.5 Cepheid Recent Development
    • 12.5 Dako
      • 12.5.1 Dako Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Oncology Molecular Diagnostics Introduction
      • 12.5.4 Dako Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.5.5 Dako Recent Development
    • 12.6 Danaher
      • 12.6.1 Danaher Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Oncology Molecular Diagnostics Introduction
      • 12.6.4 Danaher Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.6.5 Danaher Recent Development
    • 12.7 Gen Probe
      • 12.7.1 Gen Probe Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Oncology Molecular Diagnostics Introduction
      • 12.7.4 Gen Probe Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.7.5 Gen Probe Recent Development
    • 12.8 Qiagen
      • 12.8.1 Qiagen Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Oncology Molecular Diagnostics Introduction
      • 12.8.4 Qiagen Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.8.5 Qiagen Recent Development
    • 12.9 Roche Diagnostics
      • 12.9.1 Roche Diagnostics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Oncology Molecular Diagnostics Introduction
      • 12.9.4 Roche Diagnostics Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.9.5 Roche Diagnostics Recent Development
    • 12.10 Siemens
      • 12.10.1 Siemens Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Oncology Molecular Diagnostics Introduction
      • 12.10.4 Siemens Revenue in Oncology Molecular Diagnostics Business (2014-2019)
      • 12.10.5 Siemens Recent Development
    • 12.11 Sysmex

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.
      Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
      In 2018, the global Oncology Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Molecular Diagnostics development in United States, Europe and China.

      The key players covered in this study
      Abbott Laboratories
      Bayer Healthcare
      Beckton Dickinson
      Cepheid
      Dako
      Danaher
      Gen Probe
      Qiagen
      Roche Diagnostics
      Siemens
      Sysmex

      Market segment by Type, the product can be split into
      PCR
      INAAT
      DNA sequencing & NGS
      In situ hybridization
      DNA microarrays
      Other

      Market segment by Application, split into
      Infectious diseases
      oncology
      Genetic tests
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Oncology Molecular Diagnostics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Oncology Molecular Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now